(IPAY) |
| 0 (0%) 10-10 16:20 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 60.01 |
| Resistance 1: | 58.62 |
| Pivot price: | 57.89 |
| Support 1: | 56.38 |
| Support 2: | 46.91 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 07 Oct 2025
CMS Issues Final Guidance on IPAY 2028 Drug Price Negotiation Program, 2026-28 MFP Effectuation - RamaOnHealthcare
Thu, 02 Oct 2025
The payment service iPay .ua blocked the user's payment "due to NSDC sanctions." She claims that this could have happened due to a simple coincidence of surnames. How did this become possible - dev.ua
Wed, 10 Sep 2025
Launch of Facepay Plus on VietinBank iPay Mobile: Enhanced security, absolute peace of mind for your digital account - VietinBank
Thu, 26 Jun 2025
NPC Submits Comments to CMS Regarding IPAY 2028 Draft Guidance - National Pharmaceutical Council
Mon, 05 May 2025
From Uncertainty to Opportunity: Navigating IPAY 2028 - Pharmaceutical Executive
Thu, 13 Feb 2025
CMS Announces Selected Drugs for 2027 Maximum Fair Price Negotiations; New Administration Issues Executive Order Affecting the IRA - Then Clarifies - Lexology
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
